Replies to post #456795 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Not hard at all!
The MCap of SAVA is $900M vs. 3 times less for $AVXL, but before the failed Excellence readout they were about the same.

t's still hard to reconcile the share price difference between SAVA and AVXL. Any thought on that?

It is very straightforward, but apparently really hard for some to understand? I guess because Georgejjl keeps telling you the Excellence trial didn't fail.